nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCB1—kidney cancer	0.184	1	CbGaD
Sumatriptan—SLCO1B1—Pazopanib—kidney cancer	0.0685	0.132	CbGbCtD
Sumatriptan—ABCG2—Pazopanib—kidney cancer	0.0544	0.105	CbGbCtD
Sumatriptan—ABCG2—Dactinomycin—kidney cancer	0.0498	0.0958	CbGbCtD
Sumatriptan—ABCG2—Erlotinib—kidney cancer	0.0388	0.0747	CbGbCtD
Sumatriptan—ABCB1—Temsirolimus—kidney cancer	0.0374	0.0719	CbGbCtD
Sumatriptan—ABCG2—Paclitaxel—kidney cancer	0.0355	0.0684	CbGbCtD
Sumatriptan—ABCG2—Sorafenib—kidney cancer	0.0316	0.0607	CbGbCtD
Sumatriptan—ABCG2—Vincristine—kidney cancer	0.0307	0.059	CbGbCtD
Sumatriptan—ABCG2—Sunitinib—kidney cancer	0.0256	0.0492	CbGbCtD
Sumatriptan—ABCB1—Pazopanib—kidney cancer	0.0196	0.0378	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—kidney cancer	0.0192	0.0369	CbGbCtD
Sumatriptan—ABCB1—Dactinomycin—kidney cancer	0.0179	0.0345	CbGbCtD
Sumatriptan—ABCB1—Gemcitabine—kidney cancer	0.0142	0.0273	CbGbCtD
Sumatriptan—ABCB1—Erlotinib—kidney cancer	0.014	0.0269	CbGbCtD
Sumatriptan—ABCB1—Paclitaxel—kidney cancer	0.0128	0.0247	CbGbCtD
Sumatriptan—ABCB1—Sorafenib—kidney cancer	0.0114	0.0219	CbGbCtD
Sumatriptan—ABCB1—Vinblastine—kidney cancer	0.0112	0.0216	CbGbCtD
Sumatriptan—ABCB1—Vincristine—kidney cancer	0.0111	0.0213	CbGbCtD
Sumatriptan—ABCB1—Sunitinib—kidney cancer	0.00922	0.0177	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—kidney cancer	0.00691	0.0133	CbGbCtD
Sumatriptan—Eletriptan—PTGS1—kidney cancer	0.000423	0.439	CrCbGaD
Sumatriptan—Melatonin—CYP1A1—kidney cancer	0.000336	0.348	CrCbGaD
Sumatriptan—Eletriptan—ABCB1—kidney cancer	0.000206	0.213	CrCbGaD
Sumatriptan—Dyspnoea—Gemcitabine—kidney cancer	7.16e-05	0.000273	CcSEcCtD
Sumatriptan—Nausea—Vinblastine—kidney cancer	7.14e-05	0.000273	CcSEcCtD
Sumatriptan—Somnolence—Gemcitabine—kidney cancer	7.14e-05	0.000273	CcSEcCtD
Sumatriptan—Convulsion—Paclitaxel—kidney cancer	7.13e-05	0.000272	CcSEcCtD
Sumatriptan—Migraine—Doxorubicin—kidney cancer	7.12e-05	0.000272	CcSEcCtD
Sumatriptan—Nausea—Everolimus—kidney cancer	7.11e-05	0.000272	CcSEcCtD
Sumatriptan—Diarrhoea—Sorafenib—kidney cancer	7.11e-05	0.000272	CcSEcCtD
Sumatriptan—Hypertension—Paclitaxel—kidney cancer	7.11e-05	0.000272	CcSEcCtD
Sumatriptan—Pruritus—Sunitinib—kidney cancer	7.08e-05	0.00027	CcSEcCtD
Sumatriptan—Angiopathy—Capecitabine—kidney cancer	7.04e-05	0.000269	CcSEcCtD
Sumatriptan—Immune system disorder—Capecitabine—kidney cancer	7.01e-05	0.000268	CcSEcCtD
Sumatriptan—Chest pain—Paclitaxel—kidney cancer	7.01e-05	0.000268	CcSEcCtD
Sumatriptan—Myalgia—Paclitaxel—kidney cancer	7.01e-05	0.000268	CcSEcCtD
Sumatriptan—Arthralgia—Paclitaxel—kidney cancer	7.01e-05	0.000268	CcSEcCtD
Sumatriptan—Mediastinal disorder—Capecitabine—kidney cancer	7e-05	0.000267	CcSEcCtD
Sumatriptan—Anxiety—Paclitaxel—kidney cancer	6.99e-05	0.000267	CcSEcCtD
Sumatriptan—Decreased appetite—Gemcitabine—kidney cancer	6.98e-05	0.000266	CcSEcCtD
Sumatriptan—Hypersensitivity—Dactinomycin—kidney cancer	6.98e-05	0.000266	CcSEcCtD
Sumatriptan—Chills—Capecitabine—kidney cancer	6.96e-05	0.000266	CcSEcCtD
Sumatriptan—Arrhythmia—Capecitabine—kidney cancer	6.93e-05	0.000265	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Gemcitabine—kidney cancer	6.93e-05	0.000265	CcSEcCtD
Sumatriptan—Discomfort—Paclitaxel—kidney cancer	6.93e-05	0.000265	CcSEcCtD
Sumatriptan—Fatigue—Gemcitabine—kidney cancer	6.92e-05	0.000264	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Vincristine—kidney cancer	6.92e-05	0.000264	CcSEcCtD
Sumatriptan—Dizziness—Sorafenib—kidney cancer	6.87e-05	0.000263	CcSEcCtD
Sumatriptan—Pain—Gemcitabine—kidney cancer	6.86e-05	0.000262	CcSEcCtD
Sumatriptan—Constipation—Gemcitabine—kidney cancer	6.86e-05	0.000262	CcSEcCtD
Sumatriptan—Nausea—Erlotinib—kidney cancer	6.86e-05	0.000262	CcSEcCtD
Sumatriptan—Dry mouth—Paclitaxel—kidney cancer	6.86e-05	0.000262	CcSEcCtD
Sumatriptan—Diarrhoea—Sunitinib—kidney cancer	6.84e-05	0.000261	CcSEcCtD
Sumatriptan—Asthenia—Dactinomycin—kidney cancer	6.79e-05	0.000259	CcSEcCtD
Sumatriptan—Confusional state—Paclitaxel—kidney cancer	6.78e-05	0.000259	CcSEcCtD
Sumatriptan—Erythema—Capecitabine—kidney cancer	6.76e-05	0.000258	CcSEcCtD
Sumatriptan—Dehydration—Doxorubicin—kidney cancer	6.73e-05	0.000257	CcSEcCtD
Sumatriptan—Anaphylactic shock—Paclitaxel—kidney cancer	6.72e-05	0.000257	CcSEcCtD
Sumatriptan—Oedema—Paclitaxel—kidney cancer	6.72e-05	0.000257	CcSEcCtD
Sumatriptan—Body temperature increased—Vincristine—kidney cancer	6.69e-05	0.000255	CcSEcCtD
Sumatriptan—Abdominal pain—Vincristine—kidney cancer	6.69e-05	0.000255	CcSEcCtD
Sumatriptan—Liver function test abnormal—Doxorubicin—kidney cancer	6.68e-05	0.000255	CcSEcCtD
Sumatriptan—Infection—Paclitaxel—kidney cancer	6.68e-05	0.000255	CcSEcCtD
Sumatriptan—Flatulence—Capecitabine—kidney cancer	6.66e-05	0.000254	CcSEcCtD
Sumatriptan—Dysgeusia—Capecitabine—kidney cancer	6.62e-05	0.000253	CcSEcCtD
Sumatriptan—Dizziness—Sunitinib—kidney cancer	6.61e-05	0.000253	CcSEcCtD
Sumatriptan—Feeling abnormal—Gemcitabine—kidney cancer	6.61e-05	0.000253	CcSEcCtD
Sumatriptan—Shock—Paclitaxel—kidney cancer	6.61e-05	0.000253	CcSEcCtD
Sumatriptan—Vomiting—Sorafenib—kidney cancer	6.61e-05	0.000252	CcSEcCtD
Sumatriptan—Nervous system disorder—Paclitaxel—kidney cancer	6.59e-05	0.000252	CcSEcCtD
Sumatriptan—Thrombocytopenia—Paclitaxel—kidney cancer	6.58e-05	0.000251	CcSEcCtD
Sumatriptan—Tachycardia—Paclitaxel—kidney cancer	6.56e-05	0.00025	CcSEcCtD
Sumatriptan—Rash—Sorafenib—kidney cancer	6.55e-05	0.00025	CcSEcCtD
Sumatriptan—Dermatitis—Sorafenib—kidney cancer	6.55e-05	0.00025	CcSEcCtD
Sumatriptan—Back pain—Capecitabine—kidney cancer	6.54e-05	0.00025	CcSEcCtD
Sumatriptan—Skin disorder—Paclitaxel—kidney cancer	6.53e-05	0.000249	CcSEcCtD
Sumatriptan—Headache—Sorafenib—kidney cancer	6.51e-05	0.000249	CcSEcCtD
Sumatriptan—Muscle spasms—Capecitabine—kidney cancer	6.5e-05	0.000248	CcSEcCtD
Sumatriptan—Hyperhidrosis—Paclitaxel—kidney cancer	6.5e-05	0.000248	CcSEcCtD
Sumatriptan—Diarrhoea—Dactinomycin—kidney cancer	6.48e-05	0.000247	CcSEcCtD
Sumatriptan—Gastritis—Doxorubicin—kidney cancer	6.4e-05	0.000244	CcSEcCtD
Sumatriptan—Vomiting—Sunitinib—kidney cancer	6.36e-05	0.000243	CcSEcCtD
Sumatriptan—Body temperature increased—Gemcitabine—kidney cancer	6.34e-05	0.000242	CcSEcCtD
Sumatriptan—Tremor—Capecitabine—kidney cancer	6.33e-05	0.000242	CcSEcCtD
Sumatriptan—Rash—Sunitinib—kidney cancer	6.31e-05	0.000241	CcSEcCtD
Sumatriptan—Dermatitis—Sunitinib—kidney cancer	6.3e-05	0.000241	CcSEcCtD
Sumatriptan—Abdominal distension—Doxorubicin—kidney cancer	6.29e-05	0.00024	CcSEcCtD
Sumatriptan—Hypotension—Paclitaxel—kidney cancer	6.28e-05	0.00024	CcSEcCtD
Sumatriptan—Ill-defined disorder—Capecitabine—kidney cancer	6.27e-05	0.000239	CcSEcCtD
Sumatriptan—Headache—Sunitinib—kidney cancer	6.27e-05	0.000239	CcSEcCtD
Sumatriptan—Asthma—Doxorubicin—kidney cancer	6.25e-05	0.000239	CcSEcCtD
Sumatriptan—Dysphagia—Doxorubicin—kidney cancer	6.25e-05	0.000239	CcSEcCtD
Sumatriptan—Influenza—Doxorubicin—kidney cancer	6.25e-05	0.000239	CcSEcCtD
Sumatriptan—Anaemia—Capecitabine—kidney cancer	6.25e-05	0.000239	CcSEcCtD
Sumatriptan—Hypersensitivity—Vincristine—kidney cancer	6.23e-05	0.000238	CcSEcCtD
Sumatriptan—Nausea—Sorafenib—kidney cancer	6.17e-05	0.000236	CcSEcCtD
Sumatriptan—Pancreatitis—Doxorubicin—kidney cancer	6.13e-05	0.000234	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.12e-05	0.000234	CcSEcCtD
Sumatriptan—Malaise—Capecitabine—kidney cancer	6.09e-05	0.000233	CcSEcCtD
Sumatriptan—Angina pectoris—Doxorubicin—kidney cancer	6.09e-05	0.000233	CcSEcCtD
Sumatriptan—Vertigo—Capecitabine—kidney cancer	6.07e-05	0.000232	CcSEcCtD
Sumatriptan—Asthenia—Vincristine—kidney cancer	6.07e-05	0.000232	CcSEcCtD
Sumatriptan—Syncope—Capecitabine—kidney cancer	6.06e-05	0.000231	CcSEcCtD
Sumatriptan—Paraesthesia—Paclitaxel—kidney cancer	6.03e-05	0.00023	CcSEcCtD
Sumatriptan—Vomiting—Dactinomycin—kidney cancer	6.02e-05	0.00023	CcSEcCtD
Sumatriptan—Bronchitis—Doxorubicin—kidney cancer	6.01e-05	0.00023	CcSEcCtD
Sumatriptan—Dyspnoea—Paclitaxel—kidney cancer	5.99e-05	0.000229	CcSEcCtD
Sumatriptan—Somnolence—Paclitaxel—kidney cancer	5.97e-05	0.000228	CcSEcCtD
Sumatriptan—Palpitations—Capecitabine—kidney cancer	5.97e-05	0.000228	CcSEcCtD
Sumatriptan—Rash—Dactinomycin—kidney cancer	5.97e-05	0.000228	CcSEcCtD
Sumatriptan—Nausea—Sunitinib—kidney cancer	5.94e-05	0.000227	CcSEcCtD
Sumatriptan—Loss of consciousness—Capecitabine—kidney cancer	5.94e-05	0.000227	CcSEcCtD
Sumatriptan—Pancytopenia—Doxorubicin—kidney cancer	5.94e-05	0.000227	CcSEcCtD
Sumatriptan—Cough—Capecitabine—kidney cancer	5.9e-05	0.000225	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—kidney cancer	5.85e-05	0.000223	CcSEcCtD
Sumatriptan—Decreased appetite—Paclitaxel—kidney cancer	5.84e-05	0.000223	CcSEcCtD
Sumatriptan—Hypertension—Capecitabine—kidney cancer	5.83e-05	0.000223	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.8e-05	0.000222	CcSEcCtD
Sumatriptan—Fatigue—Paclitaxel—kidney cancer	5.79e-05	0.000221	CcSEcCtD
Sumatriptan—Diarrhoea—Vincristine—kidney cancer	5.79e-05	0.000221	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—kidney cancer	5.77e-05	0.000221	CcSEcCtD
Sumatriptan—Asthenia—Gemcitabine—kidney cancer	5.76e-05	0.00022	CcSEcCtD
Sumatriptan—Myalgia—Capecitabine—kidney cancer	5.75e-05	0.00022	CcSEcCtD
Sumatriptan—Chest pain—Capecitabine—kidney cancer	5.75e-05	0.00022	CcSEcCtD
Sumatriptan—Arthralgia—Capecitabine—kidney cancer	5.75e-05	0.00022	CcSEcCtD
Sumatriptan—Pain—Paclitaxel—kidney cancer	5.75e-05	0.000219	CcSEcCtD
Sumatriptan—Constipation—Paclitaxel—kidney cancer	5.75e-05	0.000219	CcSEcCtD
Sumatriptan—Anxiety—Capecitabine—kidney cancer	5.73e-05	0.000219	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—kidney cancer	5.71e-05	0.000218	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—kidney cancer	5.69e-05	0.000217	CcSEcCtD
Sumatriptan—Discomfort—Capecitabine—kidney cancer	5.68e-05	0.000217	CcSEcCtD
Sumatriptan—Pruritus—Gemcitabine—kidney cancer	5.68e-05	0.000217	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—kidney cancer	5.66e-05	0.000216	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—kidney cancer	5.64e-05	0.000215	CcSEcCtD
Sumatriptan—Dry mouth—Capecitabine—kidney cancer	5.63e-05	0.000215	CcSEcCtD
Sumatriptan—Nausea—Dactinomycin—kidney cancer	5.62e-05	0.000215	CcSEcCtD
Sumatriptan—Dizziness—Vincristine—kidney cancer	5.59e-05	0.000214	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—kidney cancer	5.57e-05	0.000213	CcSEcCtD
Sumatriptan—Confusional state—Capecitabine—kidney cancer	5.56e-05	0.000212	CcSEcCtD
Sumatriptan—Feeling abnormal—Paclitaxel—kidney cancer	5.54e-05	0.000212	CcSEcCtD
Sumatriptan—Oedema—Capecitabine—kidney cancer	5.51e-05	0.000211	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Paclitaxel—kidney cancer	5.49e-05	0.00021	CcSEcCtD
Sumatriptan—Diarrhoea—Gemcitabine—kidney cancer	5.49e-05	0.00021	CcSEcCtD
Sumatriptan—Infection—Capecitabine—kidney cancer	5.48e-05	0.000209	CcSEcCtD
Sumatriptan—Shock—Capecitabine—kidney cancer	5.43e-05	0.000207	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—kidney cancer	5.42e-05	0.000207	CcSEcCtD
Sumatriptan—Nervous system disorder—Capecitabine—kidney cancer	5.41e-05	0.000207	CcSEcCtD
Sumatriptan—Thrombocytopenia—Capecitabine—kidney cancer	5.4e-05	0.000206	CcSEcCtD
Sumatriptan—Tachycardia—Capecitabine—kidney cancer	5.38e-05	0.000206	CcSEcCtD
Sumatriptan—Vomiting—Vincristine—kidney cancer	5.38e-05	0.000205	CcSEcCtD
Sumatriptan—Skin disorder—Capecitabine—kidney cancer	5.36e-05	0.000205	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—kidney cancer	5.34e-05	0.000204	CcSEcCtD
Sumatriptan—Urticaria—Paclitaxel—kidney cancer	5.34e-05	0.000204	CcSEcCtD
Sumatriptan—Rash—Vincristine—kidney cancer	5.33e-05	0.000204	CcSEcCtD
Sumatriptan—Hyperhidrosis—Capecitabine—kidney cancer	5.33e-05	0.000204	CcSEcCtD
Sumatriptan—Dermatitis—Vincristine—kidney cancer	5.33e-05	0.000204	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—kidney cancer	5.31e-05	0.000203	CcSEcCtD
Sumatriptan—Abdominal pain—Paclitaxel—kidney cancer	5.31e-05	0.000203	CcSEcCtD
Sumatriptan—Body temperature increased—Paclitaxel—kidney cancer	5.31e-05	0.000203	CcSEcCtD
Sumatriptan—Headache—Vincristine—kidney cancer	5.3e-05	0.000202	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—kidney cancer	5.26e-05	0.000201	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—kidney cancer	5.23e-05	0.0002	CcSEcCtD
Sumatriptan—Hypotension—Capecitabine—kidney cancer	5.15e-05	0.000197	CcSEcCtD
Sumatriptan—Vomiting—Gemcitabine—kidney cancer	5.1e-05	0.000195	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—kidney cancer	5.09e-05	0.000195	CcSEcCtD
Sumatriptan—Rash—Gemcitabine—kidney cancer	5.06e-05	0.000193	CcSEcCtD
Sumatriptan—Dermatitis—Gemcitabine—kidney cancer	5.06e-05	0.000193	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—kidney cancer	5.03e-05	0.000192	CcSEcCtD
Sumatriptan—Headache—Gemcitabine—kidney cancer	5.03e-05	0.000192	CcSEcCtD
Sumatriptan—Nausea—Vincristine—kidney cancer	5.03e-05	0.000192	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.02e-05	0.000192	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—kidney cancer	5e-05	0.000191	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—kidney cancer	4.98e-05	0.00019	CcSEcCtD
Sumatriptan—Paraesthesia—Capecitabine—kidney cancer	4.95e-05	0.000189	CcSEcCtD
Sumatriptan—Hypersensitivity—Paclitaxel—kidney cancer	4.95e-05	0.000189	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—kidney cancer	4.92e-05	0.000188	CcSEcCtD
Sumatriptan—Dyspnoea—Capecitabine—kidney cancer	4.92e-05	0.000188	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—kidney cancer	4.82e-05	0.000184	CcSEcCtD
Sumatriptan—Asthenia—Paclitaxel—kidney cancer	4.82e-05	0.000184	CcSEcCtD
Sumatriptan—Decreased appetite—Capecitabine—kidney cancer	4.79e-05	0.000183	CcSEcCtD
Sumatriptan—Nausea—Gemcitabine—kidney cancer	4.77e-05	0.000182	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Capecitabine—kidney cancer	4.76e-05	0.000182	CcSEcCtD
Sumatriptan—Fatigue—Capecitabine—kidney cancer	4.75e-05	0.000182	CcSEcCtD
Sumatriptan—Pruritus—Paclitaxel—kidney cancer	4.75e-05	0.000182	CcSEcCtD
Sumatriptan—Constipation—Capecitabine—kidney cancer	4.72e-05	0.00018	CcSEcCtD
Sumatriptan—Pain—Capecitabine—kidney cancer	4.72e-05	0.00018	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—kidney cancer	4.68e-05	0.000179	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—kidney cancer	4.66e-05	0.000178	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—kidney cancer	4.64e-05	0.000177	CcSEcCtD
Sumatriptan—Diarrhoea—Paclitaxel—kidney cancer	4.6e-05	0.000176	CcSEcCtD
Sumatriptan—Feeling abnormal—Capecitabine—kidney cancer	4.54e-05	0.000174	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—kidney cancer	4.54e-05	0.000173	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—kidney cancer	4.52e-05	0.000173	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Capecitabine—kidney cancer	4.51e-05	0.000172	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—kidney cancer	4.51e-05	0.000172	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—kidney cancer	4.49e-05	0.000171	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—kidney cancer	4.47e-05	0.000171	CcSEcCtD
Sumatriptan—Dizziness—Paclitaxel—kidney cancer	4.44e-05	0.00017	CcSEcCtD
Sumatriptan—Urticaria—Capecitabine—kidney cancer	4.38e-05	0.000167	CcSEcCtD
Sumatriptan—Abdominal pain—Capecitabine—kidney cancer	4.36e-05	0.000167	CcSEcCtD
Sumatriptan—Body temperature increased—Capecitabine—kidney cancer	4.36e-05	0.000167	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—kidney cancer	4.36e-05	0.000166	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—kidney cancer	4.29e-05	0.000164	CcSEcCtD
Sumatriptan—Vomiting—Paclitaxel—kidney cancer	4.27e-05	0.000163	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—kidney cancer	4.27e-05	0.000163	CcSEcCtD
Sumatriptan—Rash—Paclitaxel—kidney cancer	4.24e-05	0.000162	CcSEcCtD
Sumatriptan—Dermatitis—Paclitaxel—kidney cancer	4.23e-05	0.000162	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—kidney cancer	4.21e-05	0.000161	CcSEcCtD
Sumatriptan—Headache—Paclitaxel—kidney cancer	4.21e-05	0.000161	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—kidney cancer	4.19e-05	0.00016	CcSEcCtD
Sumatriptan—Hypersensitivity—Capecitabine—kidney cancer	4.06e-05	0.000155	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—kidney cancer	4.04e-05	0.000154	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—kidney cancer	4.03e-05	0.000154	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—kidney cancer	4e-05	0.000153	CcSEcCtD
Sumatriptan—Nausea—Paclitaxel—kidney cancer	3.99e-05	0.000152	CcSEcCtD
Sumatriptan—Asthenia—Capecitabine—kidney cancer	3.96e-05	0.000151	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—kidney cancer	3.93e-05	0.00015	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—kidney cancer	3.91e-05	0.000149	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—kidney cancer	3.91e-05	0.000149	CcSEcCtD
Sumatriptan—Pruritus—Capecitabine—kidney cancer	3.9e-05	0.000149	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—kidney cancer	3.85e-05	0.000147	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—kidney cancer	3.83e-05	0.000146	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—kidney cancer	3.8e-05	0.000145	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—kidney cancer	3.77e-05	0.000144	CcSEcCtD
Sumatriptan—Diarrhoea—Capecitabine—kidney cancer	3.77e-05	0.000144	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—kidney cancer	3.76e-05	0.000144	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—kidney cancer	3.71e-05	0.000142	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—kidney cancer	3.71e-05	0.000142	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—kidney cancer	3.71e-05	0.000142	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—kidney cancer	3.7e-05	0.000141	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—kidney cancer	3.66e-05	0.00014	CcSEcCtD
Sumatriptan—Dizziness—Capecitabine—kidney cancer	3.65e-05	0.000139	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—kidney cancer	3.63e-05	0.000139	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—kidney cancer	3.58e-05	0.000137	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—kidney cancer	3.53e-05	0.000135	CcSEcCtD
Sumatriptan—Vomiting—Capecitabine—kidney cancer	3.51e-05	0.000134	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—kidney cancer	3.5e-05	0.000134	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—kidney cancer	3.49e-05	0.000133	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—kidney cancer	3.48e-05	0.000133	CcSEcCtD
Sumatriptan—Rash—Capecitabine—kidney cancer	3.48e-05	0.000133	CcSEcCtD
Sumatriptan—Dermatitis—Capecitabine—kidney cancer	3.47e-05	0.000133	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—kidney cancer	3.47e-05	0.000133	CcSEcCtD
Sumatriptan—Headache—Capecitabine—kidney cancer	3.45e-05	0.000132	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—kidney cancer	3.45e-05	0.000132	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—kidney cancer	3.44e-05	0.000131	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—kidney cancer	3.32e-05	0.000127	CcSEcCtD
Sumatriptan—Nausea—Capecitabine—kidney cancer	3.28e-05	0.000125	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.24e-05	0.000124	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—kidney cancer	3.19e-05	0.000122	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—kidney cancer	3.17e-05	0.000121	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—kidney cancer	3.16e-05	0.000121	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—kidney cancer	3.09e-05	0.000118	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.07e-05	0.000117	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—kidney cancer	3.06e-05	0.000117	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—kidney cancer	3.04e-05	0.000116	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—kidney cancer	3.04e-05	0.000116	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—kidney cancer	2.93e-05	0.000112	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—kidney cancer	2.91e-05	0.000111	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—kidney cancer	2.82e-05	0.000108	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—kidney cancer	2.81e-05	0.000107	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—kidney cancer	2.81e-05	0.000107	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—kidney cancer	2.62e-05	0.0001	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—kidney cancer	2.55e-05	9.74e-05	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—kidney cancer	2.51e-05	9.61e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—kidney cancer	2.43e-05	9.29e-05	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—kidney cancer	2.35e-05	8.98e-05	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—kidney cancer	2.26e-05	8.63e-05	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—kidney cancer	2.24e-05	8.56e-05	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—kidney cancer	2.24e-05	8.55e-05	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—kidney cancer	2.23e-05	8.51e-05	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—kidney cancer	2.11e-05	8.06e-05	CcSEcCtD
Sumatriptan—SLCO1A2—Metabolism—ABCB1—kidney cancer	1.13e-05	0.000341	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CTNNA1—kidney cancer	1.12e-05	0.00034	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KIT—kidney cancer	1.12e-05	0.000339	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—APC—kidney cancer	1.12e-05	0.000339	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.12e-05	0.000338	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EIF4EBP1—kidney cancer	1.12e-05	0.000338	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HSPB1—kidney cancer	1.12e-05	0.000338	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTP1—kidney cancer	1.1e-05	0.000334	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTM1—kidney cancer	1.09e-05	0.000331	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ITPR2—kidney cancer	1.09e-05	0.000329	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.08e-05	0.000326	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—MAPK3—kidney cancer	1.07e-05	0.000325	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—POMC—kidney cancer	1.07e-05	0.000323	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.06e-05	0.00032	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—BRAF—kidney cancer	1.05e-05	0.000319	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ABCB1—kidney cancer	1.04e-05	0.000316	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PSMD7—kidney cancer	1.04e-05	0.000314	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC1—kidney cancer	1.04e-05	0.000314	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ANXA1—kidney cancer	1.04e-05	0.000314	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.04e-05	0.000314	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.03e-05	0.000312	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.03e-05	0.000311	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF2—kidney cancer	1.02e-05	0.000309	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—MAPK1—kidney cancer	1.02e-05	0.000309	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CA9—kidney cancer	1.02e-05	0.000309	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN2B—kidney cancer	1.02e-05	0.000308	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.02e-05	0.000308	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTM1—kidney cancer	1.01e-05	0.000307	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FLT1—kidney cancer	1.01e-05	0.000305	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.01e-05	0.000304	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF2—kidney cancer	1e-05	0.000303	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN2B—kidney cancer	9.97e-06	0.000302	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1R—kidney cancer	9.89e-06	0.000299	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CTNNA1—kidney cancer	9.88e-06	0.000299	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EIF4EBP1—kidney cancer	9.82e-06	0.000297	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HSPB1—kidney cancer	9.82e-06	0.000297	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—PIK3CA—kidney cancer	9.77e-06	0.000295	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1R—kidney cancer	9.68e-06	0.000293	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—KRAS—kidney cancer	9.65e-06	0.000292	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ABCB1—kidney cancer	9.64e-06	0.000291	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP1A1—kidney cancer	9.61e-06	0.000291	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RAF1—kidney cancer	9.53e-06	0.000288	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	9.51e-06	0.000288	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—POMC—kidney cancer	9.49e-06	0.000287	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTP1—kidney cancer	9.43e-06	0.000285	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2—kidney cancer	9.41e-06	0.000285	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTM1—kidney cancer	9.36e-06	0.000283	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PAK1—kidney cancer	9.33e-06	0.000282	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUNB—kidney cancer	9.33e-06	0.000282	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RAF1—kidney cancer	9.33e-06	0.000282	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2—kidney cancer	9.21e-06	0.000279	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PSMD7—kidney cancer	9.13e-06	0.000276	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC1—kidney cancer	9.13e-06	0.000276	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ANXA1—kidney cancer	9.13e-06	0.000276	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ABCB1—kidney cancer	8.92e-06	0.00027	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—PIK3CA—kidney cancer	8.87e-06	0.000268	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP1A1—kidney cancer	8.87e-06	0.000268	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FLT1—kidney cancer	8.84e-06	0.000267	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RAF1—kidney cancer	8.8e-06	0.000266	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RELA—kidney cancer	8.77e-06	0.000265	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	8.74e-06	0.000264	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ERBB2—kidney cancer	8.71e-06	0.000263	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CRABP1—kidney cancer	8.67e-06	0.000262	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTM1—kidney cancer	8.66e-06	0.000262	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—POMC—kidney cancer	8.62e-06	0.000261	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MTOR—kidney cancer	8.6e-06	0.00026	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2—kidney cancer	8.55e-06	0.000258	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.52e-06	0.000258	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.45e-06	0.000256	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2—kidney cancer	8.37e-06	0.000253	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—POMC—kidney cancer	8.34e-06	0.000252	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP1A1—kidney cancer	8.21e-06	0.000248	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUNB—kidney cancer	8.19e-06	0.000248	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PAK1—kidney cancer	8.19e-06	0.000248	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HIF1A—kidney cancer	8.14e-06	0.000246	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSC2—kidney cancer	8.12e-06	0.000246	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDKN1B—kidney cancer	8.07e-06	0.000244	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ITPR2—kidney cancer	8.06e-06	0.000244	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HIF1A—kidney cancer	7.97e-06	0.000241	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSC2—kidney cancer	7.95e-06	0.000241	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2—kidney cancer	7.89e-06	0.000239	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KDR—kidney cancer	7.79e-06	0.000236	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—POMC—kidney cancer	7.73e-06	0.000234	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCND1—kidney cancer	7.7e-06	0.000233	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—JUN—kidney cancer	7.68e-06	0.000232	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF2—kidney cancer	7.63e-06	0.000231	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KDR—kidney cancer	7.63e-06	0.000231	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CTNNB1—kidney cancer	7.62e-06	0.00023	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN2B—kidney cancer	7.6e-06	0.00023	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—POMC—kidney cancer	7.57e-06	0.000229	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTEN—kidney cancer	7.43e-06	0.000225	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1R—kidney cancer	7.38e-06	0.000223	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTT1—kidney cancer	7.35e-06	0.000222	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ACHE—kidney cancer	7.35e-06	0.000222	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.29e-06	0.00022	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APC—kidney cancer	7.17e-06	0.000217	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KIT—kidney cancer	7.17e-06	0.000217	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—kidney cancer	7.17e-06	0.000217	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RAF1—kidney cancer	7.11e-06	0.000215	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APC—kidney cancer	7.02e-06	0.000212	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KIT—kidney cancer	7.02e-06	0.000212	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—kidney cancer	7.02e-06	0.000212	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SCARB1—kidney cancer	6.96e-06	0.000211	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS1—kidney cancer	6.89e-06	0.000208	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—MAPK3—kidney cancer	6.87e-06	0.000208	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—kidney cancer	6.83e-06	0.000207	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMD7—kidney cancer	6.76e-06	0.000204	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BRAF—kidney cancer	6.74e-06	0.000204	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—MAPK3—kidney cancer	6.73e-06	0.000203	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—kidney cancer	6.71e-06	0.000203	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—kidney cancer	6.7e-06	0.000203	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—kidney cancer	6.69e-06	0.000202	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN2B—kidney cancer	6.67e-06	0.000202	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—kidney cancer	6.61e-06	0.0002	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BRAF—kidney cancer	6.6e-06	0.0002	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—MAPK1—kidney cancer	6.54e-06	0.000198	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1R—kidney cancer	6.48e-06	0.000196	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—BCHE—kidney cancer	6.41e-06	0.000194	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—MAPK1—kidney cancer	6.4e-06	0.000194	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—kidney cancer	6.37e-06	0.000193	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK3—kidney cancer	6.35e-06	0.000192	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC5A5—kidney cancer	6.33e-06	0.000191	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—kidney cancer	6.25e-06	0.000189	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RAF1—kidney cancer	6.24e-06	0.000189	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—kidney cancer	6.17e-06	0.000187	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—kidney cancer	6.17e-06	0.000187	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—kidney cancer	6.17e-06	0.000187	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—kidney cancer	6.16e-06	0.000186	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—kidney cancer	6.12e-06	0.000185	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—kidney cancer	6.12e-06	0.000185	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC2A1—kidney cancer	6.11e-06	0.000185	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—kidney cancer	6.07e-06	0.000184	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC2—kidney cancer	6.06e-06	0.000183	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—kidney cancer	6.05e-06	0.000183	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK1—kidney cancer	6.04e-06	0.000183	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.83e-06	0.000176	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—kidney cancer	5.81e-06	0.000176	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—kidney cancer	5.72e-06	0.000173	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—kidney cancer	5.7e-06	0.000173	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—kidney cancer	5.67e-06	0.000172	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RAF1—kidney cancer	5.63e-06	0.00017	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RELA—kidney cancer	5.61e-06	0.00017	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—kidney cancer	5.6e-06	0.000169	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB2—kidney cancer	5.57e-06	0.000168	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—kidney cancer	5.55e-06	0.000168	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RAF1—kidney cancer	5.51e-06	0.000167	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MTOR—kidney cancer	5.5e-06	0.000166	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RELA—kidney cancer	5.49e-06	0.000166	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB2—kidney cancer	5.45e-06	0.000165	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MTOR—kidney cancer	5.38e-06	0.000163	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—kidney cancer	5.38e-06	0.000163	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KIT—kidney cancer	5.35e-06	0.000162	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APC—kidney cancer	5.35e-06	0.000162	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—kidney cancer	5.33e-06	0.000161	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC2—kidney cancer	5.32e-06	0.000161	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—kidney cancer	5.27e-06	0.00016	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—kidney cancer	5.24e-06	0.000158	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1B—kidney cancer	5.16e-06	0.000156	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK3—kidney cancer	5.12e-06	0.000155	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—kidney cancer	5.1e-06	0.000154	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—kidney cancer	5.1e-06	0.000154	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—kidney cancer	5.09e-06	0.000154	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—kidney cancer	5.07e-06	0.000153	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1B—kidney cancer	5.05e-06	0.000153	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—kidney cancer	5.05e-06	0.000153	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—kidney cancer	5.03e-06	0.000152	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—kidney cancer	4.98e-06	0.000151	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—kidney cancer	4.94e-06	0.00015	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—kidney cancer	4.92e-06	0.000149	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JUN—kidney cancer	4.91e-06	0.000149	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—kidney cancer	4.88e-06	0.000148	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK1—kidney cancer	4.88e-06	0.000147	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CTNNB1—kidney cancer	4.87e-06	0.000147	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—kidney cancer	4.82e-06	0.000146	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JUN—kidney cancer	4.81e-06	0.000145	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CTNNB1—kidney cancer	4.77e-06	0.000144	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—kidney cancer	4.75e-06	0.000144	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KIT—kidney cancer	4.7e-06	0.000142	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APC—kidney cancer	4.7e-06	0.000142	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—kidney cancer	4.68e-06	0.000142	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.66e-06	0.000141	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—kidney cancer	4.65e-06	0.000141	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—kidney cancer	4.61e-06	0.000139	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—kidney cancer	4.6e-06	0.000139	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK3—kidney cancer	4.5e-06	0.000136	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—kidney cancer	4.47e-06	0.000135	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1A1—kidney cancer	4.44e-06	0.000134	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—kidney cancer	4.42e-06	0.000134	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—kidney cancer	4.29e-06	0.00013	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK1—kidney cancer	4.28e-06	0.000129	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—kidney cancer	4.26e-06	0.000129	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—kidney cancer	4.23e-06	0.000128	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—kidney cancer	4.2e-06	0.000127	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAF1—kidney cancer	4.2e-06	0.000127	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RELA—kidney cancer	4.18e-06	0.000126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB2—kidney cancer	4.15e-06	0.000126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MTOR—kidney cancer	4.1e-06	0.000124	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	4.09e-06	0.000124	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK3—kidney cancer	4.06e-06	0.000123	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—kidney cancer	4.04e-06	0.000122	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK3—kidney cancer	3.97e-06	0.00012	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—kidney cancer	3.95e-06	0.000119	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—kidney cancer	3.87e-06	0.000117	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK1—kidney cancer	3.86e-06	0.000117	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	3.85e-06	0.000116	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—kidney cancer	3.79e-06	0.000115	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK1—kidney cancer	3.78e-06	0.000114	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—kidney cancer	3.77e-06	0.000114	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	3.71e-06	0.000112	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAF1—kidney cancer	3.69e-06	0.000112	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RELA—kidney cancer	3.67e-06	0.000111	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—kidney cancer	3.67e-06	0.000111	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUN—kidney cancer	3.66e-06	0.000111	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB2—kidney cancer	3.65e-06	0.00011	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—kidney cancer	3.65e-06	0.00011	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	3.64e-06	0.00011	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MTOR—kidney cancer	3.6e-06	0.000109	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—kidney cancer	3.57e-06	0.000108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—kidney cancer	3.54e-06	0.000107	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—kidney cancer	3.52e-06	0.000106	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1B—kidney cancer	3.38e-06	0.000102	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	3.35e-06	0.000101	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—kidney cancer	3.31e-06	0.0001	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—kidney cancer	3.31e-06	0.0001	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	3.28e-06	9.92e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.25e-06	9.82e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—kidney cancer	3.24e-06	9.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—kidney cancer	3.22e-06	9.75e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUN—kidney cancer	3.22e-06	9.73e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—kidney cancer	3.2e-06	9.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.19e-06	9.65e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—kidney cancer	3.17e-06	9.6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—kidney cancer	3.11e-06	9.41e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK3—kidney cancer	3.03e-06	9.16e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—kidney cancer	3e-06	9.09e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—kidney cancer	2.94e-06	8.91e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.88e-06	8.71e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.81e-06	8.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.72e-06	8.23e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.66e-06	8.04e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—kidney cancer	2.64e-06	7.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—kidney cancer	2.59e-06	7.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.53e-06	7.65e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.5e-06	7.56e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—kidney cancer	2.42e-06	7.31e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—kidney cancer	2.39e-06	7.22e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—kidney cancer	2.3e-06	6.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.19e-06	6.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—kidney cancer	2.12e-06	6.42e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—kidney cancer	1.62e-06	4.91e-05	CbGpPWpGaD
